VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 116 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $493,000 | -20.6% | 28,655 | +25.5% | 0.01% | -12.5% |
| Q2 2019 | $621,000 | +6.7% | 22,825 | -25.0% | 0.01% | 0.0% |
| Q1 2019 | $582,000 | +121.3% | 30,425 | +8.7% | 0.01% | +100.0% |
| Q4 2018 | $263,000 | -70.8% | 28,000 | -41.1% | 0.00% | -63.6% |
| Q3 2018 | $900,000 | +24.3% | 47,575 | +28.3% | 0.01% | +22.2% |
| Q2 2018 | $724,000 | +29.5% | 37,075 | +24.7% | 0.01% | +28.6% |
| Q1 2018 | $559,000 | +13.4% | 29,725 | 0.0% | 0.01% | +16.7% |
| Q4 2017 | $493,000 | – | 29,725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |